Humoral and cellular immunity against bacterial and parasitic heat shock protein (HSP)60 is normal, but bona fide autoimmunity is also possible against chemically altered autologous HSP60 released by damaged or dying cells
Phylogenetically highly conserved microbial and mammalian HSP60 shows ∼55% sequence homology and, therefore, is potentially cross-reactive in people with pre-existing HSP60 immunity
In experimental models, immunization of normocholesterolaemic animals with bacterial HSP60 leads to atherosclerosis, and this process can be aggravated by increasing blood cholesterol levels
Lifelong arterial stress owing to higher blood pressure and different flow conditions compared with veins lowers the threshold for HSP60 expression upon exposure to any classic risk factor for atherosclerosis
HSP60 and adhesion molecules expressed by arterial endothelial cells can be used as a target for molecular imaging of early atherosclerotic lesions
Immunological tolerance induced by oral or nasal application of HSP60 protects against atherosclerosis; identification of HSP60-derived potentially atherogenic epitopes in mice and humans could lead to the development of vaccines
Atherosclerosis is a chronic, multifactorial disease that starts in youth, manifests clinically later in life, and can lead to myocardial infarction, stroke, claudication, and death. Although inflammatory processes have long been known to be involved in atherogenesis, interest in this subject has grown in the past 30–40 years. Animal experiments and human analyses of early atherosclerotic lesions have shown that the first pathogenic event in atherogenesis is the intimal infiltration of T cells at arterial branching points. These T cells recognize heat shock protein (HSP)60, which is expressed together with adhesion molecules by endothelial cells in response to classic risk factors for atherosclerosis. Although these HSP60-reactive T cells initiate atherosclerosis, antibodies to HSP60 accelerate and perpetuate the disease. All healthy humans develop cellular and humoral immunity against microbial HSP60 by infection or vaccination. Given that prokaryotic (bacterial) and eukaryotic (for instance, human) HSP60 display substantial sequence homology, atherosclerosis might be the price we pay for this protective immunity, if risk factors stress the vascular endothelial cells beyond physiological conditions.
Subscribe to Journal
Get full journal access for 1 year
only $17.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Thompson, R. C. et al. Atherosclerosis across 4,000 years of human history: the Horus study of four ancient populations. Lancet 381, 1211–1222 (2013).
Rokitansky, C. A. A Manual of Pathological Anatomy (Blanchard and Lea, 1855).
Mayerl, C. et al. Atherosclerosis research from past to present—on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch. 449, 96–103 (2006).
Ross, R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 340, 115–126 (1999).
Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508–519 (2006).
Wick, G. & Grundtman, C. Inflammation and Atherosclerosis (SpringerVerlag, 2012).
Nesse, R. M. & Williams, G. Why We Get Sick: the New Science of Darwinian Medicine (Vintage Books, 1996).
Wick, G., Buhr, N., Fraedrich, G. & Grundtman, C. in Inflammation and Atherosclerosis 171–196 (SpringerVerlag, 2012).
Kleindienst, R. et al. Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. Am. J. Pathol. 142, 1927–1937 (1993).
Millonig, G., Malcom, G. T. & Wick, G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 160, 441–448 (2002).
Xu, Q., Kleindienst, R., Waitz, W., Dietrich, H. & Wick, G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91, 2693–2702 (1993).
Seitz, C. S., Kleindienst, R., Xu, Q. & Wick, G. Coexpression of heat-shock protein 60 and intercellular-adhesion molecule-1 is related to increased adhesion of monocytes and T cells to aortic endothelium of rats in response to endotoxin. Lab. Invest. 74, 241–252 (1996).
Craig, E. A., Gambill, B. D. & Nelson, R. J. Heat shock proteins: molecular chaperones of protein biogenesis. Microbiol. Rev. 57, 402–414 (1993).
Young, R. A. & Elliott, T. J. Stress proteins, infection, and immune surveillance. Cell 59, 5–8 (1989).
Grundtman, C. & Wick, G. The autoimmune concept of atherosclerosis. Curr. Opin. Lipidol. 22, 327–334 (2011).
Amberger, A. et al. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 2, 94–103 (1997).
Grundtman, C., Kreutmayer, S. B., Almanzar, G., Wick, M. C. & Wick, G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 960–968 (2011).
Perschinka, H. et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 1060–1065 (2003).
Kreutmayer, S. B. et al. Dynamics of heat shock protein 60 in endothelial cells exposed to cigarette smoke extract. J. Mol. Cell. Cardiol. 51, 777–780 (2011).
Xu, Q. et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102, 14–20 (2000).
Stearns, S. C. & Koella, J. C. Evolution in Health and Disease (Oxford University Press, 2008).
Wick, G., Kleindienst, R., Dietrich, H., Xu Q. Is atherosclerosis an autoimmune disease? Trends Food. Sci. Tech. 3, 114–119 (1992).
Wick, G., Knoflach, M. & Xu, Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361–403 (2004).
Cybulsky, M. I. & Jongstra-Bilen, J. Resident intimal dendritic cells and the initiation of atherosclerosis. Curr. Opin. Lipidol. 21, 397–403 (2010).
Jongstra-Bilen, J. et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073–2083 (2006).
Millonig, G., Schwentner, C., Mueller, P., Mayerl, C. & Wick, G. The vascular-associated lymphoid tissue: a new site of local immunity. Curr. Opin. Lipidol. 12, 547–553 (2001).
Liu, P. et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 28, 243–250 (2008).
Mullick, A. E. et al. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J. Exp. Med. 205, 373–383 (2008).
Choi, J. H. et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497–505 (2009).
Packard, R. R. et al. CD11c+ dendritic cells maintain antigen processing, presentation capabilities, and CD4+ T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ. Res. 103, 965–973 (2008).
Zhu, S. N., Chen, M., Jongstra-Bilen, J. & Cybulsky, M. I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141–2149 (2009).
Bobryshev, Y. V. & Lord, R. S. Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm. Atherosclerosis 154, 15–21 (2001).
Shen, L. H. et al. Oxidized low-density lipoprotein induces differentiation of RAW264.7 murine macrophage cell line into dendritic-like cells. Atherosclerosis 199, 257–264 (2008).
Bobryshev, Y. V. Dendritic cells and their role in atherogenesis. Lab. Invest. 90, 970–984 (2010).
Bobryshev, Y. V. & Lord, R. S. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 37, 799–810 (1998).
Xu, Q. B., Oberhuber, G., Gruschwitz, M. & Wick, G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56, 344–359 (1990).
Waltner-Romen, M., Falkensammer, G., Rabl, W. & Wick, G. A previously unrecognized site of local accumulation of mononuclear cells. The vascular-associated lymphoid tissue. J. Histochem. Cytochem. 46, 1347–1350 (1998).
Dansky, H. M., Charlton, S. A., Harper, M. M. & Smith, J. D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl Acad. Sci. USA 94, 4642–4646 (1997).
Daugherty, A. et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice. J. Clin. Invest. 100, 1575–1580 (1997).
Wick, G. & Xu, Q. in The Molecular Pathology of Autoimmune Diseases (eds Theofilopoulos, A. N. & Bona, C. A.) 965–977 (Taylor & Francis, 2002).
Napoli, C. et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100, 2680–2690 (1997).
Wick, G. et al. Atherosclerosis, autoimmunity, and vascular-associated lymphoid tissue. FASEB J. 11, 1199–1207 (1997).
Millonig, G., Niederegger, H. & Wick, G. Analysis of the cellular composition of the arterial intima with modified en face techniques. Lab. Invest. 81, 639–641 (2001).
Millonig, G. et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 21, 503–508 (2001).
Kampinga, H. H. et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14, 105–111 (2009).
Ishibashi, S. et al. Hypercholesterolemia in low-density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883–893 (1993).
Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C. & Witztum, J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320, 915–924 (1989).
Merat, S., Fruebis, J., Sutphin, M., Silvestre, M. & Reaven, P. D. Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis. J. Gerontol. A Biol. Sci. Med. Sci. 55, B85–B94 (2000).
Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008).
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E. & Cook, N. R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557–1565 (2002).
Ridker, P. M. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin. Chem. 55, 209–215 (2009).
Xu, Q. et al. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. 12, 789–799 (1992).
George, J. et al. Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler. Thromb. Vasc. Biol. 19, 505–510 (1999).
Metzler, B. et al. Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 19, 1905–1911 (1999).
Xu, Q. et al. Regression of arteriosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis 123, 145–155 (1996).
Schett, G. et al. Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc. Res. 42, 685–695 (1999).
Hochleitner, B. W. et al. Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 20, 617–623 (2000).
George, J. et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138, 147–152 (1998).
George, J., Afek, A., Gilburd, B., Shoenfeld, Y. & Harats, D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38, 900–905 (2001).
Foteinos, G., Afzal, A. R., Mandal, K., Jahangiri, M. & Xu, Q. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 112, 1206–1213 (2005).
Harats, D., Yacov, N., Gilburd, B., Shoenfeld, Y. & George, J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40, 1333–1338 (2002).
Maron, R. et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708–1715 (2002).
van Puijvelde, G. H. et al. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2677–2683 (2007).
Karlin, S. & Brocchieri, L. Heat shock protein 60 sequence comparisons: duplications, lateral transfer, and mitochondrial evolution. Proc. Natl Acad. Sci. USA 97, 11348–11353 (2000).
Wick, G. & Xu, Q. Autoimmunity to heat shock proteins in atherosclerosis. Atherosclerosis 134, 289–289 (1997).
Schett, G. et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96, 2569–2577 (1995).
Schett, G. et al. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 128, 27–38 (1997).
Mayr, M. et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99, 1560–1566 (1999).
Soltys, B. J. & Gupta, R. S. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol. Int. 21, 315–320 (1997).
Xu, Q. et al. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ. Res. 75, 1078–1085 (1994).
Pfister, G. et al. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J. Cell Sci. 118, 1587–1594 (2005).
Kreutmayer, S. et al. Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis. Cell Stress Chaperones 18, 259–268 (2013).
Amberger, A. et al. Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol. Med. 5, 117–128 (1999).
Willeit, J. & Kiechl, S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: a population-based study. Arterioscler. Thromb. 13, 661–668 (1993).
Xu, Q. et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341, 255–259 (1993).
Xu, Q. et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100, 1169–1174 (1999).
Hoppichler, F. et al. Changes of serum antibodies to heat-shock protein 65 in coronary heart disease and acute myocardial infarction. Atherosclerosis 126, 333–338 (1996).
Hoppichler, F., Koch, T., Dzien, A., Gschwandtner, G. & Lechleitner, M. Prognostic value of antibody titre to heat-shock protein 65 on cardiovascular events. Cardiology 94, 220–223 (2000).
Knoflach, M. et al. T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 195, 333–338 (2007).
Kiechl, S. et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103, 1064–1070 (2001).
Gurfinkel, E. et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS Study. Eur. Heart J. 20, 121–127 (1999).
Muhlestein, J. B. et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 102, 1755–1760 (2000).
Wiesli, P. et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial. Circulation 105, 2646–2652 (2002).
Mayr, M., Kiechl, S., Willeit, J., Wick, G. & Xu, Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102, 833–839 (2000).
Mayr, M. et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck Study. Stroke 34, 610–615 (2003).
Schett, G. et al. Salivary anti-hsp65 antibodies as a diagnostic marker for gingivitis and a possible link to atherosclerosis. Int. Arch. Allergy Imm. 114, 246–250 (1997).
Ford, P. J. et al. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol. Immunol. 20, 296–302 (2005).
Bartz, S. R. et al. An Hsp60 related protein is associated with purified HIV and SIV. J. Med. Primatol. 23, 151–154 (1994).
Shamaei-Tousi, A., Halcox, J. P. & Henderson, B. Stressing the obvious? Cell stress and cell stress proteins in cardiovascular disease. Cardiovasc. Res. 74, 19–28 (2007).
Lewthwaite, J., Owen, N., Coates, A., Henderson, B. & Steptoe, A. Circulating human heat shock protein 60 in the plasma of British civil servants: relationship to physiological and psychosocial stress. Circulation 106, 196–201 (2002).
Zhang, X. et al. Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese. Circulation 118, 2687–2693 (2008).
Pockley, A. G. et al. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36, 303–307 (2000).
Pockley, A. G. et al. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens. 20, 1815–1820 (2002).
Giannessi, D. et al. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 12, 265–274 (2007).
Andrie, R. P. et al. Prevalence of intimal heat shock protein 60 homologues in unstable angina and correlation with anti-heat shock protein antibody titers. Basic Res. Cardiol. 106, 657–665 (2011).
Knoflach, M. et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 108, 1064–1069 (2003).
Knoflach, M. et al. Cardiovascular risk factors and atherosclerosis in young women: Atherosclerosis Risk factors in Female Youngsters (ARFY study). Stroke 40, 1063–1069 (2009).
Rossmann, A. et al. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp. Gerontol. 43, 229–237 (2008).
Wallin, R. P. et al. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23, 130–135 (2002).
Vabulas, R. M. et al. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276, 31332–31339 (2001).
Zanin-Zhorov, A., Nussbaum, G., Franitza, S., Cohen, I. R. & Lider, O. T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors. FASEB J. 17, 1567–1569 (2003).
Kol, A., Lichtman, A. H., Finberg, R. W., Libby, P. & Kurt-Jones, E. A. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J. Immunol. 164, 13–17 (2000).
Metzler, B. et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17, 536–541 (1997).
Perschinka, H. et al. Identification of atherosclerosis-associated conformational heat shock protein 60 epitopes by phage display and structural alignment. Atherosclerosis 194, 79–87 (2007).
Benagiano, M. et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 174, 6509–6517 (2005).
Almanzar, G. et al. Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions. J. Autoimmun. 39, 441–450 (2012).
Danesh, J., Collins, R. & Peto, R. Chronic infections and coronary heart disease: is there a link? Lancet 350, 430–436 (1997).
Ridker, P. M., Hennekens, C. H., Buring, J. E. & Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836–843 (2000).
Wick, M. C., Kremser, C., Frischauf, S. & Wick, G. In vivo molecular imaging of vascular stress. Cell Stress Chaperones 13, 263–273 (2008).
Maurovich-Horvat, P., Ferencik, M., Voros, S., Merkely, B. & Hoffmann, U. Comprehensive plaque assessment by coronary CT angiography. Nat. Rev. Cardiol. http://dx.doi.org/10.1038/nrcardio.2014.60.
Otsuka, F., Joner, M., Prati, F., Virmani, R. & Narula, J. Clinical classification of plaque morphology in coronary disease. Nat. Rev. Cardiol. http://dx.doi.org/10.1038/nrcardio.2014.62.
Tarkin, J. M., Joshi F. R. & Rudd, J. H. PET imaging of inflammation in atherosclerosis. Nat. Rev. Cardiol. http://dx.doi.org/10.1038/nrcardio.2014.80.
Wick, M. C. et al. In vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression. Cell Stress Chaperones 13, 275–285 (2008).
Davenport, P. & Tipping, P. G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163, 1117–1125 (2003).
George, J. et al. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ. Res. 86, 1203–1210 (2000).
George, J. et al. Interleukin (IL)-4 deficiency does not influence fatty streak formation in C57BL/6 mice. Atherosclerosis 153, 403–411 (2000).
King, V. L., Szilvassy, S. J. & Daugherty, A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler. Thromb. Vasc. Biol. 22, 456–461 (2002).
King, V. L., Cassis, L. A. & Daugherty, A. Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice. Am. J. Pathol. 171, 2040–2047 (2007).
Huber, S. A., Sakkinen, P., David, C., Newell, M. K. & Tracy, R. P. T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation 103, 2610–2616 (2001).
Jing, H. et al. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice. Vaccine 29, 4102–4109 (2011).
Mundkur, L. et al. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice. PLoS ONE 8, e58364 (2013).
Li, H., Ding, Y., Yi, G., Zeng, Q. & Yang, W. Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells. J. Huazhong Uni. Sci. Tech. Med. Sci. 32, 24–30 (2012).
Xiong, Q., Li, J., Jin, L., Liu, J. & Li, T. Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms. Immunol. Letters 125, 40–45 (2009).
Dubaquié, Y., Looser, R., Fünfschilling, U., Jenö, P. & Rospert, S. Identification of in vivo substrates of the yeast mitochondrial chaperonins reveals overlapping but non-identical requirement for hsp60 and hsp10. EMBO J. 17, 5868–5876 (1998).
Takizawa, S. et al. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem. Biophys. Res. Commun. 386, 192–196 (2009).
Shan, Y. X. et al. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J. Mol. Cell. Cardiol. 35, 1135–1143 (2003).
Ciervo, A., Petrucca, A., Villano, U., Fioroni, G. & Cassone, A. Low prevalence of antibodies against heat shock protein 10 of Chlamydophila pneumoniae in patients with coronary heart disease. J. Microbiol. Meth. 63, 248–253 (2005).
Mehlen, P., Schulze-Osthoff, K. & Arrigo, A. P. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem. 271, 16510–16514 (1996).
Park, H. K. et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 114, 886–893 (2006).
Cuerrier, C. M. et al. Chronic over-expression of heat shock protein 27 attenuates atherogenesis and enhances plaque remodeling: a combined histological and mechanical assessment of aortic lesions. PLoS ONE 8, e55867 (2013).
Rayner, K. et al. Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ. Res. 103, 133–141 (2008).
Martin-Ventura, J. L. et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 110, 2216–2219 (2004).
Lepedda, A. J. et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203, 112–118 (2009).
Qiu, X. B., Shao, Y. M., Miao, S. & Wang, L. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell. Mol. Life Sci. 63, 2560–2570 (2006).
Nguyen, T. Q. et al. Increased expression of HDJ-2 (hsp40) in carotid artery atherosclerosis: a novel heat shock protein associated with luminal stenosis and plaque ulceration. J. Vasc. Surg. 33, 1065–1071 (2001).
Timofeeva, A. V. et al. Altered gene expression in peripheral blood leukocytes from patients with arterial hypertension. Ann. N. Y. Acad. Sci. 1091, 319–335 (2006).
Bobryshev, Y. V. & Lord, R. S. A. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J. Vasc. Surg. 35, 368–375 (2002).
Zhu, J. et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23, 1055–1059 (2003).
Li, Z. et al. Heat shock protein 70 acts as a potential biomarker for early diagnosis of heart failure. PLoS ONE 8, e67964 (2013).
Csermely, P., Schnaider, T., Soti, C., Prohászka, Z. & Nardai, G. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129–168 (1998).
Businaro, R. et al. Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 207, 74–83 (2009).
Madrigal-Matute, J. et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc. Res. 86, 330–337 (2010).
Rose, N. R. & Bona, C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol. Today 14, 426–430 (1993).
Monzini, N., Legname, G., Marcucci, F., Gromo, G. & Modena, D. Identification and cloning of human chaperonin 10 homologue. Biochim. Biophys. Acta 1218, 478–480 (1994).
De Souza, A. I. et al. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ. Res. 97, 192–198 (2005).
Ganea, E. Chaperone-like activity of α-crystallin and other small heat shock proteins. Curr. Protein Pept. Sci. 2, 205–225 (2001).
Hino, M., Kurogi, K., Okubo, M. A., Murata-Hori, M. & Hosoya, H. Small heat shock protein 27 (HSP27) associates with tubulin/microtubules in HeLa cells. Biochem. Biophys. Res. Commun. 271, 164–169 (2000).
Jakob, U., Gaestel, M., Engel, K. & Buchner, J. Small heat shock proteins are molecular chaperones. J. Biol. Chem. 268, 1517–1520 (1993).
Sun, Y. & MacRae, T. H. Small heat shock proteins: molecular structure and chaperone function. Cell. Mol. Life Sci. 62, 2460–2476 (2005).
Becker, T., Hartl, F. U. & Wieland, F. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158, 1277–1285 (2002).
Chen, M. S., Roti Roti, J. & Laszlo, A. Hsc40, a new member of the hsp40 family, exhibits similar expression profile to that of hsc70 in mammalian cells. Gene 238, 333–341 (1999).
Hattori, H. et al. Intracellular localization and partial amino acid sequence of a stress-inducible 40 kDa protein in HeLa cells. Cell Struct. Funct. 17, 77–86 (1992).
Raabe, T. & Manley, J. L. A human homologue of the Escherichia coli DnaJ heat shock protein. Nucleic Acids Res. 19, 6645 (1991).
Metzler, B. et al. Activation of heat shock transcription factor 1 in atherosclerosis. Am. J. Pathol. 162, 1669–1676 (2003).
Green, M., Schuetz, T. J., Sullivan, E. K. & Kingston, R. E. A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function. Mol. Cell. Biol. 15, 3354–3362 (1995).
Rabindran, S. K., Giorgi, G., Clos, J. & Wu, C. Molecular cloning and expression of a human heat shock factor, HSF1. Proc. Natl Acad. Sci. USA 88, 6906–6910 (1991).
Arosa, F. A., De Jesus, O., Porto, G., Carmo, A. M. & De Sousa, M. Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. J. Biol. Chem. 274, 16917–16922 (1999).
David, V., Hochstenbach, F., Rajagopalan, S. & Brenner, M. B. Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J. Biol. Chem. 268, 9585–9592 (1993).
Dupuis, M., Schaerer, E., Krause, K. H. & Tschopp, J. The calcium-binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes. J. Exp. Med. 177, 1–7 (1993).
Lee, D. et al. Calreticulin induces dilated cardiomyopathy. PLoS ONE 8, e56387 (2013).
Ohashi, K., Burkart, V., Flohe, S. & Kolb, H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164, 558–561 (2000).
Lewis, V. A., Hynes, G. M., Zheng, D., Saibil, H. & Willison, K. T-complex polypeptide-1 is a subunit of a heteromeric particle in the eukaryotic cytosol. Nature 358, 249–252 (1992).
Li, W. Z. et al. Tcp20, a subunit of the eukaryotic TRiC chaperonin from humans and yeast. J. Biol. Chem. 269, 18616–18622 (1994).
Bukau, B. & Horwich, A. L. The Hsp70 and Hsp60 chaperone machines. Cell 92, 351–366 (1998).
Asea, A. et al. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028–15034 (2002).
Vabulas, R. M. et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277, 15107–15112 (2002).
Asea, A. et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6, 435–442 (2000).
Zhou, J. D. et al. Increased expression of heat shock protein 70 and heat shock factor 1 in chronic dermal ulcer tissues treated with laser-aided therapy. Chin. Med. J. 121, 1269–1273 (2008).
Dybdahl, B. et al. Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart 91, 299–304 (2005).
Gao, T. & Newton, A. C. The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C. J. Biol. Chem. 277, 31585–31592 (2002).
Han, Z., Truong, Q. A., Park, S. & Breslow, J. L. Two Hsp70 family members expressed in atherosclerotic lesions. Proc. Natl Acad. Sci. USA 100, 1256–1261 (2003).
Ishihara, K., Yasuda, K. & Hatayama, T. Molecular cloning, expression and localization of human 105 kDa heat shock protein, hsp105. Biochim. Biophys. Acta 1444, 138–142 (1999).
Jørgensen, M. M. et al. Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum. J. Biol. Chem. 275, 33861–33868 (2000).
Takeuchi, S. Molecular cloning, sequence, function and structural basis of human heart 150 kDa oxygen-regulated protein, an ER chaperone. Protein J. 25, 517–528 (2006).
Wan, T. et al. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103, 1747–1754 (2004).
Wisniewska, M. et al. Crystal structures of the ATPase domains of four human Hsp70 isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70–2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78. PLoS ONE 5, e8625 (2010).
Binder, R. J., Vatner, R. & Srivastava, P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64, 442–451 (2004).
Basu, S., Binder, R. J., Ramalingam, T. & Srivastava, P. K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14, 303–313 (2001).
Maki, R. G., Old, L. J. & Srivastava, P. K. Human homologue of murine tumor rejection antigen gp96: 5-regulatory and coding regions and relationship to stress-induced proteins. Proc. Natl Acad. Sci. USA 87, 5658–5662 (1990).
Meunier, L., Usherwood, Y. K., Tae Chung, K. & Hendershot, L. M. A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol. Biol. Cell 13, 4456–4469 (2002).
Liu, B. et al. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat. Commun. 1, 79 (2010).
Obermann, W. M., Sondermann, H., Russo, A. A., Pavletich, N. P. & Hartl, F. U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143, 901–910 (1998).
Ho Yeong, S., Dunbar, J. D., Yuan Xin, Z., Guo, D. & Donner, D. B. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270, 3574–3581 (1995).
Felts, S. J. et al. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J. Biol. Chem. 275, 3305–3312 (2000).
Uray, K., Hudecz, F., Füst, G. & Prohászka, Z. Comparative analysis of linear antibody epitopes on human and mycobacterial 60-kDa heat shock proteins using samples of healthy blood donors. Int. Immunol. 15, 1229–1236 (2003).
Choi, J. I. et al. Epitope mapping of Porphyromonas gingivalis heat-shock protein and human heat-shock protein in human atherosclerosis. J. Dent. Res. 83, 936–940 (2004).
Wysocki, J. et al. Human heat shock protein 60 (409–424) fragment is recognized by serum antibodies of patients with acute coronary syndromes. Cardiovasc. Pathol. 11, 238–243 (2002).
The authors acknowledge funding from: the European Union FP7Large-Scale Integrated Project, Novel Approaches to Reconstitute Normal Immune Function at Old Age (TOLERAGE HEALTH-F4-2008-202156), coordinated by G.W. and C.G.; the Austrian Research Fund (FWF) Grant P198810-B05 to G.W.; the Medizinische Forschungsförderung Innsbruck MFI (Project 9443) to M.C.W.; the Lore and Udo Saldow-Donation to G.W. and B.J.; the Tiroler Wissenschaftsfonds Project “The role of Vascular Associated Lymphoid Tissue (VALT) in the Development of Atherosclerosis–Inside Out or Outside In” to B.J.; and the Translational Research Project “T-Oral” to G.W. and M.B.
The authors declare no competing financial interests.
Amino acid sequence of heat shock proteins and their reactive T-cell and B-cell epitopes from human samples (DOCX 86 kb)
Induction and tolerization of atherosclerosis with heat shock proteins and their reactive T-cell epitopes in experimental animals (DOCX 38 kb)
About this article
Cite this article
Wick, G., Jakic, B., Buszko, M. et al. The role of heat shock proteins in atherosclerosis. Nat Rev Cardiol 11, 516–529 (2014). https://doi.org/10.1038/nrcardio.2014.91
Suppression of microRNA-155 exerts an anti-inflammatory effect on CD4+ T cell-mediated inflammatory response in the pathogenesis of atherosclerosis
Acta Biochimica et Biophysica Sinica (2020)
Frontiers in Molecular Biosciences (2020)
Arteriosclerosis, Thrombosis, and Vascular Biology (2020)
Heat shock transcription factor 1 regulates the fetal γ-globin expression in a stress-dependent and independent manner during erythroid differentiation
Experimental Cell Research (2020)
Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL
PLOS ONE (2020)